Literature DB >> 17544272

Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517.

Imadul Islam1, Greg Brown, Judi Bryant, Paul Hrvatin, Monica J Kochanny, Gary B Phillips, Shendong Yuan, Marc Adler, Marc Whitlow, Dao Lentz, Mark A Polokoff, James Wu, Jun Shen, Janette Walters, Elena Ho, Babu Subramanyam, Daguang Zhu, Richard I Feldman, Damian O Arnaiz.   

Abstract

Based on the lead compound BX-517, a series of C-4' substituted indolinones have been synthesized and evaluated for PDK1 inhibition. Modification at C-4' of the pyrrole afforded potent compounds (7b and 7d) with improved solubility and ADME properties. In this letter, we describe the synthesis, selectivity profile, and pharmacokinetic data of selected compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544272     DOI: 10.1016/j.bmcl.2007.05.060

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer.

Authors:  Giulia Nesi; Simona Sestito; Valentina Mey; Simona Ricciardi; Marco Falasca; Romano Danesi; Annalina Lapucci; Maria C Breschi; Stefano Fogli; Simona Rapposelli
Journal:  ACS Med Chem Lett       Date:  2013-10-18       Impact factor: 4.345

2.  Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.

Authors:  Kumiko Nagashima; Stuart D Shumway; Sriram Sathyanarayanan; Albert H Chen; Brian Dolinski; Youyuan Xu; Heike Keilhack; Thi Nguyen; Maciej Wiznerowicz; Lixia Li; Bart A Lutterbach; An Chi; Cloud Paweletz; Timothy Allison; Youwei Yan; Sanjeev K Munshi; Anke Klippel; Manfred Kraus; Ekaterina V Bobkova; Sujal Deshmukh; Zangwei Xu; Uwe Mueller; Alexander A Szewczak; Bo-Sheng Pan; Victoria Richon; Roy Pollock; Peter Blume-Jensen; Alan Northrup; Jannik N Andersen
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

3.  Structure-based CoMFA and CoMSIA study of indolinone inhibitors of PDK1.

Authors:  Kirandeep Kaur; Tanaji T Talele
Journal:  J Comput Aided Mol Des       Date:  2008-09-09       Impact factor: 3.686

Review 4.  PDK1 inhibitors.

Authors:  Elisa Barile; Surya K De; Maurizio Pellecchia
Journal:  Pharm Pat Anal       Date:  2012-05

5.  AutoGPA: An Automated 3D-QSAR Method Based on Pharmacophore Alignment and Grid Potential Analysis.

Authors:  Naoyuki Asakawa; Seiichi Kobayashi; Junichi Goto; Noriaki Hirayama
Journal:  Int J Med Chem       Date:  2012-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.